ZIP: a novel transcription repressor, represses EGFR oncogene and suppresses breast carcinogenesis.

Ruifang Li,Hua Zhang,Wenhua Yu,Yupeng Chen,Bin Gui,Jing Liang,Yan Wang,Luyang Sun,Xiaohan Yang,Yu Zhang,Lei Shi,Yanyan Li,Yongfeng Shang

DOI: https://doi.org/10.1038/emboj.2009.211

2009-01-01

Abstract:Despite the importance of epidermal growth factor receptor (EGFR) in animal development and malignant transformation, surprisingly little is known about the regulation of its expression. Here, we report a novel zinc finger and G-patch domain-containing protein, ZIP. We demonstrated that ZIP acts as a transcription repressor through the recruitment of the nucleosome remodelling and deacetylase complex. Transcriptional target analysis revealed that ZIP regulates several cellular signalling pathways including EGFR pathways that are critically involved in cell proliferation, survival, and migration. We showed that ZIP inhibits cell proliferation and suppresses breast carcinogenesis, and that ZIP depletion leads to a drastic tumour growth in vivo. We found that ZIP is downregulated in breast carcinomas and that its level of expression is negatively correlated with that of EGFR. Our data indicate that ZIP is a novel transcription repressor and a potential tumour suppressor. These findings may shed new light on the EGFR-related breast carcinogenesis and might offer a potential new target for breast cancer therapy. The EMBO Journal (2009) 28, 2763-2776. doi: 10.1038/emboj.2009.211; Published online 30 July 2009